GALAPAGOS NV's ticker is GLPG and the CUSIP is 36315X101. A total of 110 filers reported holding GALAPAGOS NV in Q2 2021. The put-call ratio across all filers is 2.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $27,727,895 | -0.1% | 802,544 | +17.6% | 9.21% | -8.0% |
Q2 2023 | $27,757,118 | -8.2% | 682,664 | -12.7% | 10.01% | -1.2% |
Q1 2023 | $30,227,647 | +249.6% | 782,289 | +301.5% | 10.14% | +178.7% |
Q4 2022 | $8,646,822 | -32.7% | 194,836 | -20.2% | 3.64% | -37.8% |
Q3 2021 | $12,848,000 | +1566.4% | 244,205 | +2342.0% | 5.85% | +1305.3% |
Q1 2021 | $771,000 | – | 10,000 | – | 0.42% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 250,680 | $13,188,000 | 7.26% |
Stonepine Capital Management, LLC | 244,205 | $12,848,000 | 5.85% |
Sio Capital Management, LLC | 224,719 | $11,822,000 | 3.77% |
EcoR1 Capital, LLC | 1,558,749 | $82,006,000 | 2.85% |
BVF INC/IL | 1,119,733 | $58,909,000 | 2.30% |
683 Capital Management, LLC | 701,421 | $36,902,000 | 1.44% |
DAFNA Capital Management LLC | 77,675 | $4,086,000 | 1.08% |
Soleus Capital Management, L.P. | 115,300 | $6,066,000 | 0.94% |
APOGEM CAPITAL LLC | 19,267 | $1,014,000 | 0.64% |
Orbimed Advisors | 723,457 | $38,061,000 | 0.42% |